A quantum leap
Film director Mark Levinson often gets asked for advice from people looking to break into the movie-making business. “I tell them, ‘The good news is I didn’t go to film school. The bad news is I got a Ph.D. in physics,’” he says with a laugh.Mark Levinson Image courtesy of PF Productions
While Levinson’s atypical career path is probably not the ideal template for aspiring filmmakers, it is illustrative of his perspective about the unexpected overlap between science and cinema. The “creative impulse is very similar,” he points out. “I think (that similarity) underlines my whole transition.”
Levinson the scientist started out in an M.D./Ph.D. program at Brown University before a professor turned him onto theoretical physics. Even though his passion for science led him to pursue a graduate physics degree at the University of California, Berkeley, Levinson admits that his interests tended to go beyond academia. “I was fascinated by art and artists and how they interacted with society and what their role was,” he says.
A fan of classic movies like “2001: A Space Odyssey” and “They Shoot Horses, Don’t They?,” Levinson was nonetheless unaware that he could work in the film industry until he was introduced to the films of European directors Lina Wertmüller and Rainer Werner Fassbinder. Observing their distinctive styles helped Levinson become “very conscious of directors.”
Becoming more and more enamored with the idea of working in the film industry, Levinson did what seemingly every Hollywood hopeful does: “I started writing a script,” he says. But even then, Levinson didn’t feel like his career had really made much of a change. “I went from being a graduate student in theoretical physics, where I was sitting in a room, by myself, scratching on pencil and paper, not making money,” he remembers. “And then I was writing a script, and I was sitting in a room, by myself, not making much money and scratching on pencil and paper.” Yet the bigger challenge for Levinson was trying to live with the feeling that he had disappointed his graduate adviser. “It was probably the hardest part,” he admits.
When Levinson first entered the film industry, he scuttled through a series of jobs in various departments until he finally ended up in the editing room. While working there in 1987, he got to meet the acclaimed film editor Walter Murch, who already had won an Academy Award for his work on “Apocalypse Now.” Surprisingly, Levinson’s scientific training was the catalyst for his meeting with Murch.
“I was an apprentice editor in the same building where he was editing ‘The Unbearable Lightness of Being,’” recalls Levinson. “He heard that there was somebody in the building with a Ph.D. in physics, so he sent his assistant down to ask me if I’d go to lunch with him and talk to him about string theory.” Levinson went on to work with Murch on “The English Patient” (which fetched Murch his second Oscar), “The Talented Mr. Ripley” and “Cold Mountain.”
Despite becoming fully immersed in the glamorous world of Hollywood, Levinson always was tempted to use the opportunities afforded by the movie industry to showcase science. “I had never really seen a film that I thought accurately depicted how science really works,” he says. Levinson’s worlds finally collided with the 2013 release of “Particle Fever,” a documentary he directed that follows researchers at the European Council for Nuclear Research in their quest to detect the Higgs boson using the Large Hadron Collider.Full view of the open ATLAS DetectorImage courtesy of CERN
Rather than follow a standard documentary formula of telling a story through a single pair of eyes, the movie instead relies on six scientists to show the scientific process at work, thereby bringing a human side to research. “We needed to choose people that could bring out the various elements” of the experience, explains Levinson, pointing out that the film’s protagonists range from a fresh-faced postdoctoral fellow to a senior administrator at CERN. “The focus for me always was ‘How are we going to tell a good dramatic story?’” says Levinson.
“Particle Fever” was met with overwhelmingly positive reviews and numerous accolades, including the Audience Award at the 2013 Sheffield International Documentary Festival and both the Grand Jury and Brainstorm Prizes at the 2013 360° Contemporary Science Film Festival. It also enabled Levinson to resolve any lingering guilt about his decision to abandon scientific research all those years ago: One of his most gratifying moments with “Particle Fever” was the positive reception it got from his graduate school adviser. “I feel like maybe I wasn’t a complete disappointment to him in the end,” Levinson says. “‘Particle Fever’ is my gift back to the physics community.”
The success of “Particle Fever” motivated Levinson to continue exploring the overlap between his two passions of art and science. He is working on a film adaptation of Richard Powers’ novel “The Gold Bug Variations.” Titled in reference to Johann Sebastian Bach’s famous work called the “Goldberg Variations” and the Edgar Allan Poe short story “The Gold-Bug,” the novel tells of a young molecular biologist working on the genetic code in the 1950s who derails his scientific career in pursuit of love and music.CERN's Globe of Science and Innovation at nightPhoto courtesy of PF Productions
From his vantage point, Levinson sees science and cinema as two endeavors where “man is trying to find a representation of the world around him to understand it in some deeper way.” Indeed, in making “Particle Fever,” Levinson says, his interest in the overlap between science and art has reenergized his own belief in the importance of both realms: “These are the things that make us human,” he says.
Join the ASBMB Today mailing list
Sign up to get updates on articles, interviews and events.
For small-molecule cancer drugs, context is everything. Drugs that ameliorate cancer in some tissues may increase the cancer risk in others. Researcher Stephen Safe has turned this challenge into an opportunity.
Awards, promotions, milestones and more. Find out what's going on in the lives of ASBMB members.
Wayne Fairbrother leads a department at Genentech tasked with validating disease-associated targets and determining whether they could be feasible for drug development.